Urinary Kallidinogenase

尤瑞克林

Report date: 2022/08/26 14:15:11
NME

Base Information

Drug NameUrinary Kallidinogenase
Drug Alias Name人尿激肽原酶凯力康TP-388
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEnzyme replacementsKininogens stimulantsPlatelet aggregation inhibitors
TargetsKininogens
Therapy Area/IndicationsCerebral Infarction
Global Approved IndicationsCerebral Infarction
Approved Indications in ChinaCerebral Infarction
Original Approved Country/TerritoryMainland China
Original Approved Date2005/10/19
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTechpool Bio-Pharma Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Inactive CompaniesN/A
Active IndicationsCerebral Infarction
Inactive IndicationsN/A

Other Information

ATC CodeC04AF01
Related LinksN/A